Variable
|
OR
|
LCL
|
UCL
|
---|
Overweighta,b
|
1.02
|
0.67
|
1.24
|
Obesea,b
|
0.75*
|
0.60
|
0.95
|
Overweight or obesea,b
|
0.77*
|
0.62
|
0.95
|
WC elevateda,c
|
0.79*
|
0.64
|
0.99
|
Elevated systolic BPd
|
0.91
|
0.71
|
1.17
|
Elevated diastolic BPd
|
1.03
|
0.80
|
1.33
|
LDL-C elevatedd,e
|
0.80
|
0.57
|
1.14
|
HDL-C reducedd,e
|
0.85*
|
0.67
|
1.07
|
Triglycerides elevatedd,e
|
0.81
|
0.58
|
1.13
|
Glucose elevatedd,e
|
0.81
|
0.59
|
1.11
|
Insulin elevated (>85th Pctl)d
|
0.82
|
0.54
|
1.26
|
Metabolic syndromea,f
|
0.74
|
0.52
|
1.05
|
- Abbreviations: WC = Waist circumference, BP = Blood pressure, LDL-C = Low-density lipoprotein cholesterol, HDL-C = High-density lipoprotein cholesterol
- For Tree Nut Consumers, the reference group was no tree nut consumption
- aCovariates: Gender, Ethnicity, Age, Socioeconomic Status (PIR 0–1.25, 1.25-3.4, ≥ 3.25), Physical Activity Level (sedentary, moderate, active), Current Smoker Status, and Alcohol
- bOveweight was defined as a BMI 25–29.9; obese was defined as a BMI ≥ 30; overweight or obese was defined as a BMI ≥25
- cElevated WC was defined as >102 cm (males), >88 cm (females)
- dCovariates: Gender, Ethnicity, Age, Socioeconomic Status (PIR 0–1.25, 1.25-3., ≥ 3.25), Physical Activity Level (sedentary, moderate, active), Current Smoker Status, Alcohol, and BMI
- eReduced HDL-cholesterol was defined as <40 mg/dL (males), <50 mg/dL (females); high triglycerides, ≥150 mg/dL or taking anti-hyperlipidemic medications; high fasting glucose, ≥110 mg/dL or taking insulin or other hypoglycemic agents. Elevated LDL-C ≥100 mg/dL
- fMetabolic syndrome was defined using the National Heart Lung and Blood Institute Adult Treatment Panel III criteria; that is having 3 or more of the following risk factors: abdominal obesity, WC > 102 cm (males), >88 cm (females); hypertension, SBP ≥130 mmHg or DBP ≥85 mmHg or taking anti-hypertensive medications; HDL-cholesterol, <40 mg/dL (males), <50 mg/dL (females); high triglycerides, ≥150 mg/dL or taking anti-hyperlipidemic medications; high fasting glucose, ≥110 mg/dL or taking insulin or other hypoglycemic agents
- *p < 0.05